Do elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence?
PMP patients with elevated CEA, or more than one abnormal serum tumour maker, are at risk of developing recurrent disease.
Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway.